Colberg appointed chair of the AMSilk GmbH Supervisory Board

Dr. Wolfgang Colberg appointed chair of the AMSilk GmbH supervisory board

Planegg, March 31, 2016

Dr. Wolfgang Colberg has been named the newest member of the Supervisory Board at AMSilk GmbH, the world’s first industrial supplier of synthetic silk biopolymers. Dr. Colberg has taken over the chair of the board. The AMSilk Supervisory Board has a total of three members: Dr. Colberg, Dr. Matthias Kromayer (Member of the Board of MIG Fonds) and Siegfried Winkelbeiner (CEO of Schoeller Textil AG).

Dr. Colberg has been an industrial partner at the private equity firm CVC Capital Partners since 2013. In July 2015, Dr. Colberg became the CEO of the CVC investment company ChemicaInvest Holding BV in the Netherlands. Prior to that, he was CFO at Evonik Industries AG, one of the world’s leading manufacturers of specialty chemicals, as well as CFO at BSH Bosch und Siemens Hausgeräte GmbH. He also held different management positions within the Bosch Group in Germany and abroad, and he is the Independent Director at Pernod Ricard SA, France. Dr. Colberg completed his studies of business administration at the University of Kiel with a doctorate.

“We are very pleased to welcome Dr. Colberg as a member of the Supervisory Board at AMSilk. We are convinced that thanks to his many years of industry experience Dr. Colberg will be a major asset to us in the current commercialization phase of our functional silk biopolymers,” states Jens Klein, CEO of AMSilk.

“I am impressed by the wide-ranging spectrum of applications for AMSilk biopolymers. Internationally marketing such an innovative high-performance material is an exciting challenge and I look forward to contribute my experience to the successful development of the company,” says Dr. Wolfgang Colberg.

About AMSilk

AMSilk GmbH is the world’s first industrial supplier of synthetic silk biopolymers and has its headquarters in Planegg near Munich, Germany. Sustainably produced using a patented biotechnological process, AMSilk biopolymers have the unique functional properties of the natural product they are based on. The organic high-performance material can be used in multiple ways, including in medical or technical products as well as cosmetic ingredients. AMSilk biopolymers give everyday products unique properties. Among other things, the polymers are biocompatible, breathable and especially robust.

AMSilk biopolymers are distributed in the form of Silkbeads (microparticles), Silkgel (hydrogel) or Biosteel® (fibers). They are currently used in coatings for medical-technology products, in the textile industry and as an ingredient in personal-care products.

www.amsilk.com

For further information please contact:

AMSilk GmbH
Anja Mayer
Phone: +49 (0)89 57 95 393-0
Email: pr@amsilk.com

Kirchhoff Consult AG
Anja Ben Lekhal
Tel: +49 (0)40 60 91 86-55
E-mail: anja.benlekhal@kirchhoff.de

Also
interesting

AMSilk appoints new CEO

31.12.2020 | CEO Jens Klein is leaving AMSilk on December 31, 2020 to assume a new role outside of the company. Ulrich Scherbel is appointed as new CEO.